Efficacy and Saftey of Artemether-Lumefantrine with Single Dose Primaquine for Treatment of Uncomplicated Plasmodium Falciparum Malaria in Arbaminch, Southwest Ethiopia

Simple item page
dc.contributor.advisorEyasu Makonnen
dc.contributor.authorBontu Abate
dc.date.accessioned2025-08-13T06:21:01Z
dc.date.available2025-08-13T06:21:01Z
dc.date.issued2024-04-13
dc.description.abstractIn Ethiopia, 60% of the population resides in areas prone to malaria infection. The first-line treatment for uncomplicated Plasmodium falciparum (P. falciparum) infection in Ethiopia is artemether-lumefantrine (AL), as outlined in the national malaria diagnosis and treatment guideline. The World Health Organization (WHO) recommends monitoring the efficacy of first-line antimalarial drugs at least once every two years post-implementations. Such information is crucial for assessing resistance levels and implementing timely interventions
dc.identifier.urihttps://etd.aau.edu.et/handle/123456789/6576
dc.language.isoen_US
dc.publisherAddis Ababa University
dc.subjectMalaria
dc.subjectTreatment
dc.subjectEfficacy
dc.subjectSafety
dc.subjectArtemether-Lumefantrine
dc.subjectP. falciparum
dc.subjectEthiopia
dc.titleEfficacy and Saftey of Artemether-Lumefantrine with Single Dose Primaquine for Treatment of Uncomplicated Plasmodium Falciparum Malaria in Arbaminch, Southwest Ethiopia
dc.typeThesis

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Bontu Abate.pdf
Size:
940.18 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Clinical Trials